logo-loader
Eden Research

Eden Research gets 'emergency use' green light for Mevalone in France

Eden Research PLC's (LON:EDEN) Sean Smith tells Proactive London's Andrew Scott their fungicide, Mevalone, has been granted 120-day emergency use authorisation in France for the treatment of storage diseases on apples.

Smith says the emergency use approval represents the first authorisation for the use of Mevalone on apples and for the treatment of post-harvest storage diseases.

Quick facts: Eden Research

Price: £0.10

Market: AIM
Market Cap: £21 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Eden Research named herein, including the promotion by the Company of Eden Research in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Bluebird Merchant outlines Kochang drill plans, Jubilee Metals makes...

Top stories from the Proactive Investors newsroom this morning: Korean gold explorer Bluebird Merchant Ventures Ltd (LON:BMV)  is to start drilling at its Kochang mine in July after receiving confirmation of a grant from local mining group KORES.  The initial subsidy will help...

on 9/5/19

2 min read